▲ Peaking
Health
Why Three Minutes Of Sprinting May Beat An Hour+ Spent Exercising
New findings suggest that just three minutes of sprinting may offer health benefits superior to over an hour of traditional exercise.
Obesity
29 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✗
There's One Genetic Variant That Makes The Body Burn Fat Instead of Storing It
A million-person genetic study identifies a protective metabolic variant that shifts the body toward burning fat.
◼ Archived
Health
🔮 fades ✓
Supercharged by Social Media, the GLP-1 Boom Is Warping Teen Psyches
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
GLP-1 use tied to obesity decline, but doctors warn of alarming misuse
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✓
GLP-1 weight loss drugs: What experts say about keeping weight off after stopping
GLP-1 weight loss drugs are trending as usage hits new highs in the US and experts address long-term treatment challenges.
◼ Archived
Health
🔮 fades ✓
One in eight U.S. adults uses GLP-1 drugs; Medicare now opens weight-loss access
One in eight U.S. adults now uses GLP-1 drugs as Medicare officially opens weight-loss access.
◼ Archived
Health
🔮 fades ✓
Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism
New research reveals that distinct brain regions control food intake based on whether GIPR receptors are stimulated or blocked.
◼ Archived
Business
🔮 fades
Eli Lilly’s Anticipated Weight Loss Drug Helped People Lose 56 Pounds On Average
Eli Lilly's retatrutide shows significant weight loss results in Phase 3 trials, paving the way for a 2027 FDA approval filing.
◼ Archived
Business
🔮 fades
Eli Lilly’s Next-Generation Weight-Loss Shot Clears Another Hurdle
Eli Lilly targets a first-quarter 2027 FDA application for its next-generation obesity drug retatrutide.
◼ Archived
Business
🔮 fades
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data
Eli Lilly is moving toward 2027 regulatory filings for retatrutide after successful Phase 3 obesity trials showing significant weight and A1C improvements.
◼ Archived
Health
🔮 fades
GLP-1 use rising rapidly among US adolescents and young adults, study finds
GLP-1 weight-loss medications are seeing a surge in adoption among adolescents and children globally, shifting treatment patterns for youth obesity.
◼ Archived
Health
🔮 fades
More young women in their 20s are getting type 2 diabetes
Medical warnings are increasing as data reveals a surge of type 2 diabetes cases among young women, particularly those in their 20s.
◼ Archived
Health
🔮 fades
This GLP-1 retreat changed how I think about weight loss
Emerging trends in GLP-1 medications highlight an expansion beyond weight loss, including therapeutic retreats and rising use among young adults.
◼ Archived
Health
🔮 fades
Seattle breakthrough offers Spokane boy relief from rare hunger condition
A breakthrough therapy approved by the FDA provides relief for a Spokane boy suffering from rare hypothalamic obesity caused by a brain injury.
◼ Archived
Health
🔮 fades
Too many Britons are too fat to work
A new study reveals that obesity is preventing more than 600,000 people in the United Kingdom from participating in the workforce.
◼ Archived
Health
🔮 fades
An avocado a day keeps the doctor away: new study
Recent studies examine how daily avocado consumption impacts heart disease risk, cholesterol, and cognitive function.
◼ Archived
Health
🔮 fades
GLP-1’s Reduce Binge Eating Symptoms
Emerging research suggests GLP-1 receptor agonists may provide a promising treatment for binge eating disorder and emotional eating symptoms.
◼ Archived
Health
🔮 fades
GLP-1 Weight Loss Drug Use Triples, as Obesity Declines
GLP-1 weight loss drug use triples while overall obesity declines, sparking intense medical debate.
◼ Archived
Health
🔮 fades
Men’s Average Testosterone Levels Have Halved in 50 years
A global study indicates that average male testosterone levels have decreased by approximately half over the last 50 years.
◼ Archived
Business
🔮 fades
U.S. Obesity Rate Drops As GLP-1 Usage Grows
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Statins helping people with obesity match those of healthy weight on key metrics, study finds
New research suggests that statin use is narrowing the disparity in heart health metrics between individuals with obesity and those of a healthy weight.
◼ Archived
Health
🔮 fades
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
◼ Archived
Health
🔮 fades
About 170,000 people in England expected to die from obesity-linked heart conditions by 2035
Rising obesity rates in England threaten 170,000 lives by 2035 as cardiovascular risks escalate.
◼ Archived
Business
🔮 fades
Seniors in Medicare are about to get landmark obesity drug coverage
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks
Research into GLP-1 receptor agonists is shifting focus from weight management to potential longevity benefits and broader therapeutic applications.
◼ Archived
Health
🔮 fades
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Oral GLP-1 medications are gaining attention as clinical data emerges regarding their efficacy in weight management and potential to shift treatment paradigms.
◼ Archived
Health
🔮 fades
GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Medicare weight-loss drug coverage could overwhelm doctors
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades
Adiposity and cancer: epidemiology, mechanisms and future perspectives
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.